Tag: gastroesophageal junction (GEJ) adenocarcinoma

Home / gastroesophageal junction (GEJ) adenocarcinoma

Categories

Pembrolizumab receives accelerated approval from the FDA for HER2-positive gastric cancer

August 2021: Pembrolizumab (Keytruda, Merck & Co.) in combination with trastuzumab, fluoropyrimidine-, and platinum-containing chemotherapy has been granted accelerated approval by the Food and Dr...
gastroesophageal-junction-gej-adenocarcinoma

We Are Online! Chat With Us!
Scan the code